Compare Cronos Group Inc (CRON) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Rivian Automotive, Inc. — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Rivian Automotive, Inc. trades at $14.31 (market cap $20.75B). The key difference: Rivian Automotive, Inc. is far larger — about 17.6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Rivian Automotive, Inc. for 61 Days on average.
| CRON | RIVN | |
|---|---|---|
Market Cap | $1.18B | $20.75B |
Volume | 968,037 | 26,144,654 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $22.45 |
52-Week Low | $2.30 | $12.50 |
Typical Hold Time | 22 Days | 61 Days |
Enterprise Value | $387.62M | $20.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Rivian Automotive (RIVN) trades at $14.34, down 1.17% on the day, reflecting a bearish technical outlook despite recent record Q3 2026 deliveries of 19,248 vehicles. The company continues to post significant net losses, with a -54.95% net income margin for 2025, though revenue growth is evident, rising to $5.39B. Analyst consensus is mixed, with a $16.89 price target, but cash burn remains a concern with negative operating cash flow.
The outlook hinges on R2 production scaling and future profitability; upside exists if Rivian achieves cost reductions and autonomy tech gains traction, but high cash burn, competitive pressures, and execution risks pose substantial threats to shareholder value in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
